occupational health

The Human Cost of Respiratory Care: Why Multidisciplinary Teams Cannot Shield Physicians from Burnout

By MedXY 03/19/2026

A comprehensive study of 569 cystic fibrosis professionals identifies physicians as the group most vulnerable to burnout, emotional exhaustion, and depersonalization. The research highlights administrative burden as a primary driver and calls for urgent systems-level reforms to protect the respiratory workforce.

news Oncology Public Health

China’s Workforce Faces Alarming Cancer Risk Profiles: New Baseline Data from the WECAN Project

By MedXY 02/23/2026

A cross-sectional analysis of 841 workers across China reveals a high prevalence of modifiable cancer risk factors, including poor diet, smoking, and low screening rates. The study highlights significant regional disparities, calling for targeted workplace-based prevention strategies.

Cardiology news Public Health

Beyond the Lead Apron: New Evidence of High Orthopedic and Reproductive Risks in Cardiac Electrophysiology

By MedXY 12/25/2025

A global Heart Rhythm Society survey reveals that 41% of EP professionals suffer from orthopedic injuries and 50% of women face pregnancy complications, highlighting the urgent need for systemic improvements in laboratory ergonomics and radiation safety protocols.

news Oncology Public Health

Occupation Matters: New Data Reveal Wide Disparities in US Cancer Mortality Among Working-Age Adults

By MedXY 12/23/2025

A comprehensive population study of 450,453 deaths identifies specific occupations, including fishing, mining, and funeral services, with disproportionately high cancer mortality, suggesting a complex interplay of workplace exposures and structural inequities.

Infectious Diseases Medical News news Nursing & care Specialties

Long COVID and the Workforce: Navigating a Complex Path Back to Employment

By MedXY 08/05/2025

Long COVID is keeping millions of workers out of the workforce, with significant barriers to compensation and treatment. Standardized diagnostics, validated therapies, and regulatory reforms are urgently needed to support affected individuals and the healthcare system.